Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
NeoGenomics, Inc. specializes in oncology diagnostic testing and consultative services, including molecular, cytogenetic, and histopathology analyses. Operating laboratories in the U.S. and U.K., it serves healthcare providers, pharmaceutical companies, and research institutions. The company offers comprehensive cancer testing, interpretation, and data solutions, leveraging advanced technologies like NGS and liquid biopsies to support personalized medicine and drug development. Its core focus is improving patient outcomes through high-quality, innovative cancer diagnostics.
This description was generated via AI from an annual report. Updated about 1 year ago.